Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04720768
Title Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE (CELEBRATE)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Peter MacCallum Cancer Centre, Australia
Indications

melanoma

Therapies

Binimetinib + Encorafenib + Palbociclib

Age Groups: senior | adult
Covered Countries

Additional content available in CKB BOOST